Form D Explorer

Inspect source fieldsReport a record issue

Form D — Iambic Therapeutics, Inc.

0001997038-25-000002 · filed Nov 21, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$124,999,970
Reported amount sold
$99,269,270
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Iambic Therapeutics, Inc.
CIK
1997038
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
5627 OBERLIN DRIVE, SUITE 120
SAN DIEGO, California 92121
Phone
(619) 330-5499

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗